Skip Navigation

Who we are

We come from all around the world, bringing literally thousands of years of combined knowledge and expertise to our mission. We are specialists in biosimilar medicines creation, all along the value chain from cell line development to commercial manufacturing.

What we do

Our biosimilar assets include several biosimilar monoclonal antibodies and fusion proteins that are developed in our research & development centers located across Europe and are manufactured in our state-of-the-art facility in Reykjavik, Iceland.

We develop, produce and release our biosimilars in-house with the latest available technology and to the highest quality standards for the supply of finished and ready to commercialize products to our partners worldwide.

Our vision

Our vision is to set a new standard for the future of biopharmaceuticals by bringing high quality biosimilars to market for life-threatening diseases for patients around the world.